Clinical trialNCT03391778RecruitingPhase 1Interventional

Adoptive Cell Therapy Long-term Follow-up (LTFU) Study

SponsorUSWM CT, LLCEnrollment250Neoplasms

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Michael Nathenson, MD
USWM CT, LLC
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
Jayesh Desai
Recruiting

Canada

Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Adrian Sacher
Recruiting
Hôpital Maisonneuve-Rosemont
Montreal, Quebec, Canada
Jonathan Noujaim
Recruiting

Germany

Klinikum Rechts Der Isar Der Technischen Universität München
Munich, Bavaria, Germany
Lars Lindner
Recruiting
Uniklinik Köln
Cologne, North Rhine-Westphalia, Germany
Roland Ullrich
Recruiting

Italy

Fondazione Irccs - Istituto Nazionale Dei Tumori
Milan, Lombardy, Italy
Silvia Stacchiotti
Recruiting

Netherlands

Antoni Van Leeuwenhoek Ziekenhuis
Amsterdam, Netherlands
John B.A.G. Haanen
Recruiting

Spain

Hospital Universitario Virgen del Rocío
Seville, Spain
Pilar Sancho Márquez
Recruiting

United Kingdom

University College London Hospitals Nhs Foundation Trust
London, United Kingdom
Sandra Strauss
Recruiting
Uswm Ct Investigational Site
Manchester, United Kingdom
Fiona Thistlethwaite
Recruiting
the Royal Marsden Nhs Foundation Trust
Sutton, United Kingdom
Andrew Furness
Recruiting

United States

Emory University School of Medicine
Atlanta, Georgia, United States
Melinda Yushak
Recruiting
Adp Investigational Site
Baltimore, Maryland, United States
Aaron Rapoport
Recruiting
National Cancer Institute - Center for Cancer Research
Bethesda, Maryland, United States
Completed
University of Michigan
Ann Arbor, Michigan, United States
Rashmi Chugh
Recruiting
Washington University School of Medicine in St. Louis
St Louis, Missouri, United States
Brian Van Tine
Recruiting
Memorial Sloan Kettering Cancer Center - New York
New York, New York, United States
Sandra P D'Angelo
Recruiting
Duke University Medical Center
Durham, North Carolina, United States
Richard Riedel
Recruiting
Oregon Health and Science University
Portland, Oregon, United States
Lara Davis
Recruiting
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Edward A Stadtmauer
Recruiting
University of Pittsburgh Medical Center (upmc) Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
Melissa Burgess
Recruiting
University of Texas Southwestern Medical Center
Dallas, Texas, United States
John Samuel
Recruiting
University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Dejka Araujo
Recruiting
Froedtert Hospital
Milwaukee, Wisconsin, United States
John A Charlson
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 9 Apr 2018
Primary completion: 1 Apr 2032
Completion: 1 Apr 2032
Last update posted: 3 Mar 2026
Registered enrollment: 250
Registry id: NCT03391778

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.